We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Painkiller Linked to Overdose Deaths

By HospiMedica staff writers
Posted on 11 Dec 2001
Print article
Following a review of autopsy data, officials of the US Drug Enforcement Administration (DEA) have concluded that the painkiller OxyContin was a factor in the overdose deaths of 110 people over the last 19 months. The study did not attempt to determine whether the drug alone was responsible for the deaths since the deaths involved multiple drugs.

Previously, overdose deaths by people taking OxyContin were believed to have been caused by people snorting or injecting crushed pills, a faster and more dangerous way to take the drug. However, the federal review showed that almost all of the overdose deaths were of people who had swallowed OxyContin whole or crushed into powder. Since the beginning of 2000, federal officials say around 500 people have died from overdoses involving oxycodone, the addictive narcotic in the drug and in other painkillers. However, they were unable to determine if all the overdoses were caused by OxyContin.

Recently, the manufacturer of OxyContin, Purdue Pharma L.P. (Stamford, CT) announced the beginning of clinical studies of a new drug containing oxycodone in a controlled-release formulation with an opiod antagonist, naloxone. The new version is designed to reduce intravenous abuse of OxyContin tablets. If the tablet is crushed and injected, the naloxone is released into the bloodstream, where it counteracts the effect of the oxycodone, diminishing the euphoria sought by the abuser. However, the recent findings that almost all the OxyContin-linked overdose deaths were of people who swallowed the drug would appear to indicate that this new version of OxyContin may not solve the abuse problem.




Related Links:
Purdue Pharma
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Pediatric Phlebotomy Chair
2665M2 Extra Wide Pediatric Phlebotomy Chair
New
Mattress Replacement System
Apollo Infant Dynamic

Print article

Channels

Surgical Techniques

view channel
Image: The Trilogy Valve with locator technology is the only TAVI system approved for aortic regurgitation (Photo courtesy of JenaValve)

New Transcatheter Valve Found Safe and Effective for Treating Aortic Regurgitation

Aortic regurgitation is a condition in which the aortic valve does not close properly, allowing blood to flow backward into the left ventricle. This results in decreased blood flow from the heart to the... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.